Diffuse follicle center lymphoma, intrathoracic lymph nodes is a type of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells within the lymph nodes located in the thoracic cavity. This condition is clinically significant due to its potential for aggressive behavior and the need for accurate diagnosis and treatment. The ICD-10 Code C82.52 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this malignancy.
ICD-10 Code C82.52 represents Diffuse follicle center lymphoma affecting the intrathoracic lymph nodes. This condition involves the abnormal growth of B-lymphocytes, leading to lymphadenopathy and potential systemic symptoms. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Diffuse follicle center lymphoma, intrathoracic lymph nodes is a hematological malignancy that arises from the transformation of B-cells within the lymphatic system. It can progress rapidly, leading to significant morbidity if not addressed promptly. Medical attention is crucial for diagnosis and management, including chemotherapy or radiation therapy.
ICD-10 Code C82.52 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to diffuse follicle center lymphoma. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's clinical status and facilitating appropriate management.
In SOAP notes, ICD-10 Code C82.52 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse follicle center lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of diffuse follicle center lymphoma, intrathoracic lymph nodes often requires hospitalization for intensive treatment. Chemotherapy regimens and supportive care are critical components of the treatment plan.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.52 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C82.52 for Diffuse follicle center lymphoma, intrathoracic lymph nodes
What are the common symptoms of diffuse follicle center lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience respiratory symptoms if lymph nodes in the thoracic cavity are affected.
How is diffuse follicle center lymphoma diagnosed?
Diagnosis typically involves a combination of imaging studies, such as CT scans, and biopsy of affected lymph nodes to confirm the presence of neoplastic B-cells.
What treatment options are available for this condition?
Treatment options may include chemotherapy, radiation therapy, and supportive care. The specific regimen depends on the stage and aggressiveness of the lymphoma.
Is diffuse follicle center lymphoma contagious?
No, diffuse follicle center lymphoma is not contagious. It is a malignancy that arises from genetic mutations in B-cells and is not transmitted between individuals.
Clinical Notes
SOAP notes
DAP notes
AI medical notes